Congratulations to Dr. Angela Smith on their recent elections to the Board of Directors for the Society of Women in Urology (SWIU). Dr. Smith will serve a 2-year term on the Board and is currently holding the position as the Member-At-Large.
The SWIU Board of Directors is composed of a diverse group of women representing a wide spectrum of urologic subspecialties, various stages in academic or clinical careers, and a variety of institutions or practices in the United States.
“I am excited to join an impressive group of women leaders on the Board of Directors for the Society of Women in Urology, uniting in our mission to support the professional advancement of women urologists, encourage public education regarding urologic issues, and promote urologic research.”
Angela B. Smith, MD, MS, FACS
Vice Chair of Academic Affairs
Director of Urologic Oncology
Associate Professor of Urology
About The Society of Women in Urology (SWIU)
The Society of Women in Urology (SWIU), formerly known just as “Women in Urology,” informally began at the 1980 AUA meeting in San Francisco, when five female urologists met for breakfast to discuss their experiences. Such informal meetings continued until 1992 when the group created an executive board and introduced bylaws.
SWIU now has more than 950 members, including over 300 board-certified female urologists, as well as female researchers, urology residents, fellows, post-residency, pre-board-certified women. SWIU also has female members who are non-urology MDs and PhDs.
About Dr. Smith
Dr. Angela Smith is the Director of Urologic Oncology at the UNC Lineberger Comprehensive Cancer Center and primarily treats GU malignancies, including bladder, prostate, and kidney cancer.
Dr. Smith has a background in health services research and biostatistics and has an interest in patient-centered outcomes research, risk stratification, and quality of care for invasive bladder cancer.
Dr. Smith is the co-PI for a PCORI large pragmatic trial in BCG refractory bladder cancer, PI for a PCORI Engagement Award with the Bladder Cancer Advocacy Network to engage patients in the research process, and has been funded by an AHRQ K08 grant that integrates patient-reported outcomes into post-cystectomy care through mobile health technology.
Dr. Smith has also served on the PCORI Advisory Panel for the Assessment of Prevention, Diagnosis, and Treatment Options, representing clinicians. Dr. Smith also serves as the Assistant Secretary of the American Urological Association and has recently served on the AUA Quality Improvement and Patient Safety Committee, Scientific Advisory Board for the Bladder Cancer Advocacy Network, Journal of Urology Editorial Board, and is the current chair of the Urology Care Foundation Bladder Health Committee.